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ABSTRACT 
• Presentation for respiratory (RD) disease comprised 1.3 per cent of cat, 1.1 per cent of dog, and 
1.3 per cent of rabbit consultations, from January to December 2017.  
• Sneezing was the most frequent respiratory sign reported in cats (45.2 per cent); in dogs it was 
coughing (71.7 per cent).  
• Canine respiratory coronavirus (CRCoV) was identified in 43 samples from dogs, the highest 
percentage testing positive in autumn and winter, with a peak in September (5.6 per cent of 
positive samples). 
• From 2010 to 2017, there were 197 laboratory samples from which Streptococcus equi subs. 
zooepidemicus was cultured, 22 from cats, 144 from dogs and 31 from Guinea Pigs. Of the 136 
canine samples for which anatomical sampling location was known, 75 (55.1 per cent) were from 
the respiratory tract (nose, trachea or oropharynx). 
About this report 
This report is the fifth in a series by the Small Animal Veterinary Surveillance Network (SAVSNET). This 
report focuses on respiratory disease in companion animals and analyses one year of data from 392 
veterinary premises across the United Kingdom (UK), from January to December 2017.  
 2 
 
In the first section, we focus on surveillance for respiratory disease from the SAVSNET veterinary 
practices. Next we describe canine respiratory coronavirus (CRCoV) infections in dogs and we present 
the results from the laboratory-confirmed cases in dogs across the country. This is followed by an 
update on the temporal trends of three important syndromes in companion animals, namely 
gastroenteritis, pruritus, and respiratory disease, from 2014 to 2017. A third section presents a brief 
update on Streptococcus equi subspecies zooepidemicus in companion animals. The final section 
summarises some recent developments pertinent to companion animal health, namely eyeworm 
infestations (Thelazzia callipaeda) and canine influenza virus in the United States of America and 
Canada.  
Key words: small animal, disease surveillance, respiratory disease, canine respiratory coronavirus, 
Streptococcus equi subs. zooepidemicus 
 
Syndromic surveillance of respiratory disease 
Respiratory diseases are common in companion animals. Although clinical signs such as coughing and 
dyspnoea are commonly referable to primary problems of the respiratory tract, they may also occur 
secondary to disorders of other organ systems (e.g., cardiac failure). Both young and aged animals are 
at increased risk of developing respiratory disease. At birth, the respiratory and immune systems are 
incompletely developed; this facilitates the introduction and spread of pathogens within the lungs. In 
aged animals, chronic degenerative changes may render the lungs more vulnerable to airborne 
pathogens and toxic particulates (Kuehn, 2018).  
The present report considers an update of companion animals presented with respiratory disease to 
the SAVSNET, from January to December 2017. 
This report is based on EHRs for 311,646 consultations in cats, 737,056 consultations in dogs and 
16,172 consultations in rabbits (including repeat consultations for the same animal). Presentation with 
respiratory disease, as indicated by the veterinary surgeon’s categorisation, comprised 1.3 per cent of 
cat, 1.1 per cent of dog, and 1.3 per cent of rabbit consultations. Compared to our previous report 
from April 2016 (Sánchez-Vizcaíno et al., 2016), when presentation for respiratory disease comprised 
2.3 per cent of cat, 1.7 per cent of dog and 2.5 per cent of rabbit consultations ; in 2017 we observed 
a decrease of number of consultations for respiratory disease of 42 per cent in cats, 35 per cent for 
dogs and 48 per cent for rabbits, respectively. Considering that in 2016, we collected a similar number 
of EHRs (1,000,245), our current results show an overall decrease of number of consultations for 
respiratory disease. 
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Short questionnaires were completed for 988 cats and 2089 dogs randomly selected from those 
animals presenting with respiratory disease. The most common presenting sign in dogs was a cough 
(71.7 per cent), compared to cats which most frequently reported sneezing (45.2 per cent) (Figure 1, 
Table 1). The majority of clinical signs were acute, observed for less than a week (42.1 per cent of cats 
and 49.1 per cent of dogs). These results are in line with our previous report for respiratory disease 
(Sánchez-Vizcaíno et al., 2016). However, compared to our previous report on respiratory disease, 
36.4 per cent of cats and 28.7 per cent of dogs had persisting clinical signs of one month or longer. 
Therefore, it was perhaps of no surprise that the surveyed animals were equally frequently presented 
for a first visit (47.6 per cent of cats 56.3 per cent of dogs) as for a subsequent check-up (52.4 per cent 
of cats and 43.7 per cent of dogs). These results require further investigations regarding risk factors 
for persistence of moderate and chronic respiratory illness. 
 
Spatial distribution of respiratory disease 
The spatial distribution of the relative risk (RR) for respiratory disease was evaluated in dogs and cats 
in England and Wales for each season of the surveillance period (Figure 1). Estimates for Scotland and 
Northern Ireland were not ascertained because SAVSNET geographical coverage in these areas is 
currently limited. Details of the method are described elsewhere (Sánchez-Vizcaíno et al., 2015). 
In cats, the areas of highest RR (higher than 0.51) were fragmented and seemed transient depending 
on the season. For example, central areas of England and Wales had an increased RR in autumn and 
summer, and coastal areas of England and Wales in spring and winter. In comparison, dogs showed 
relatively few areas of variable RR, with zones with higher than 0.41 appearing in spring in Cumbria 
and in winter in Gwynedd. These patterns in cats and dogs were similar to those from our previous 
report on respiratory disease (Sánchez-Vizcaíno et al., 2016). We intend to further investigate the 
underlying factors that contribute to variations of RR.  
 
Laboratory-based investigations of Canine respiratory coronavirus 
Canine respiratory coronavirus (CRCoV) was relatively recently identified by polymerase chain 
reaction (PCR) in tracheal and lung samples from dogs residing in a high turnover UK rescue center 
with enzootic respiratory disease despite regular vaccination. From 40 samples tested, 7 were found 
to be positive by PCR and subsequent hybridization (17.5 per cent) (Erles et al., 2003). Since then, 
CRCoV has been reported worldwide.  
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Infected dogs show clinical to subclinical respiratory illness with coughing, sneezing, nasal discharge 
and eventually bronchitis. Dogs of all ages are susceptible to infection, with a peak of CRCoV cases 
between 2 and 8 years of age (Erles and Brownlie, 2008). No CRCoV vaccines are available so isolation 
of infected dogs is necessary to minimize transmission. Treatment consists of supportive therapy. 
There is no evidence that CRCoV can infect other animal species or people (Erles and Brownlie, 2008). 
Data collected from January 2010 to December 2017 were used to identify trends in the proportion of 
canine samples testing positive by a PCR-based assay following sample submissions to UK-based 
laboratories participating in SAVNET. In total, CRCoV was identified in 43 samples. There were 2.3 
times more positive samples from male (n=28) than female dogs (n=12); in a further three cases, sex 
was not recorded. Although CRCoV was diagnosed in each calendar month across all years, overall 
positive cases were higher in autumn and winter (Figure 2), in particular in September 2017 (12.9 per 
cent of positive samples from submissions for that given month) and October 2013 (12.5 per cent of 
positive samples from submissions for that given month). An earlier longitudinal study conducted 
among dogs from training centres in England also showed a seasonal pattern of CRCoV infection, with 
most cases being reported in October and November (Erles and Brownlie, 2005). However, further 
studies in the UK should evaluate if CRCoV appears to be getting more or less common. 
 
Update on the temporal trends of the main syndromes in companion animals  
This section briefly describes the temporal trends in the syndromic surveillance of gastroenteritis, 
pruritus and respiratory disease as recorded by veterinary practices participating in SAVSNET in 2017, 
and compared to all previous years (2014-2016) (Figure 3).  
In 2017 we consultations for gastrointestinal disease constituted on average 19 per 1000 weekly 
consultations in cats and 29 per 1000 weekly consultations in dogs. As in earlier reports (Arsevska et al., 
2017; Sánchez-Vizcaíno et al., 2015), in 2017 gastrointestinal disease showed a seasonal pattern which 
was particularly apparent in dogs, where animals were less likely to present in summer and early 
autumn. The week with the highest rate of canine consultations reported with gastroenteritis in 2017 
was in December (38 per 1000 consultations in week 52). In cats, the highest weekly rate of consultations 
were observed in December and February (26 per 1000 consultations in weeks 6 and 52, respectively). 
Similar patterns of seasonality of gastrointestinal disease were also observed in previous years, with 
however a higher rate of consultations. For example in dogs the highest weekly rate of visits for 
gastrointestinal disease was 80 per 1000 consultations in week 53 in 2016 and 60 per 1000 consultations 
in week 52 in 2014. In cats the rate of visits was 54 per 1000 consultations in week 52 in 2014 and 44 
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per 1000 consultations in week 53 in 2016. High rates in these weeks may reflect variable presentation 
to veterinary practices associated with Christmas holidays. 
On average throughout 2017, pruritus was reported more commonly in dogs (44 per 1000 weekly 
consultations) than cats (22 per 1000 weekly consultations). Overall, pruritus in dogs appeared to have 
a seasonal pattern, with increased percentages of consultations in autumn; a similar although less 
pronounced pattern was observed for cats (Figure 3). In 2017, the week with the highest proportion of 
consultations for pruritus in cats and dogs was in November (weeks 43 and 44) with 53 per 1000 
consultations in dogs and 30 consultations per 1000 consultations in cats. Compared to previous years, 
in 2017 we observed a decrease in the number of visits for pruritus (the weekly average rate in previous 
years in dogs was 60 per 1000 weekly consultations and 34 per 1000 weekly consultations in cats) 
(Arsevska et al., 2017).  
In 2017, respiratory disease was more commonly recorded in cats (average of 11 per 1000 weekly 
consultations) than dogs (on average 9 per 1000 weekly consultations). The trend of respiratory disease 
was more stable throughout all months of the year (Figure 3). As for the other syndromes, the overall 
rate of consultations recorded for respiratory disease in 2017 decreased in comparison to the period 
2014 to 2016 (on average 18 per 1000 weekly consultations in cats and 13 per 1000 weekly consultations 
in dogs). 
Update on Streptococcus zooepidemicus  in companion animals   
Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) is a gram positive, beta-haemolytic 
bacterium that has been associated for many years with opportunistic infections, predominantly in 
the reproductive tract, in horses and curiously with lymphadenitis in guinea pigs (Gruszynski et al., 
2015). In recent years the bacterium has emerged as a significant cause of pneumonia in dogs, notably 
those housed in kennels or rehoming centres, and particularly amongst racing greyhounds (Priestnall 
and Erles, 2011).  
Infection is usually sporadic but often serious, resulting in severe, and not infrequently fatal, 
pneumonia. The source of infections is usually unknown but presumed to be introduced into a canine 
population by a carrier animal. Although transmission from horses to dogs has been considered as the 
main primary source of infection (Acke et al., 2010), it is now thought (similar to canine influenza) that 
transmission and infection now occurs mainly directly between dogs without the need for contact 
with horses. Close contact is required to transmit from one animal to another and densely housed 
dogs or those with a weakened immune response due to concurrent respiratory viral infection appear 
to the most severely affected. The bacteria produces various exotoxins and it is thought the most 
serious disease manifestations are as a result of the animal’s immune response to these so-called 
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“superantigens”, resulting in a “cytokine storm”, similar to toxic shock syndrome in humans (Paillot et 
al., 2010; Priestnall et al., 2010). 
A number of outbreaks of haemorrhagic pneumonia in dogs have been reported from around the 
world attributed to infection with S. zooepidemicus, usually occurring as infection with a single clone 
of the bacterium within a shelter and resulting in high rates of morbidly and mortality (FitzGerald et 
al., 2017; Pesavento et al., 2008).  
Dogs infected with S. zooepidemicus may begin with clinical signs of upper respiratory tract infection 
(nasal discharge, coughing); this initial presentation resembles ‘kennel cough’ such that specific 
diagnosis may be missed. Affected dogs can rapidly progress to pyrexia, lethargy, inappetance and, if 
untreated, hypovolemic shock. Key warning signs for pneumonia development would be pyrexia and 
marked lethargy. In confirmed cases, treatment is largely supportive aimed at rapid, intravenous 
broad-spectrum antibiotic administration and fluid therapy. Dogs can recover from infection if treated 
early. Clinicians should be alert with any fatality due to respiratory disease in groups of dogs prompting 
swift investigation (Jaeger et al., 2013). At necropsy dogs have severe fibrino-suppurative, necrotising 
and haemorrhagic pneumonia with copious haemorrhagic pleural effusion and often petechial 
haemorrhages on the pleural surfaces (Priestnall et al., 2010). 
Confirmation of infection can be done via routine bacterial culture from oropharyngeal, or preferably 
nasal swabs. More rapid (real-time PCR-based) diagnostics have been developed and when validated, 
should provide for more timely diagnosis and earlier treatment. There are few differential diagnoses 
for haemorrhagic pneumonia in dogs but in the last 3 or 4 years cases of extra-intestinal E.coli infection 
have produced similar rapidly progressing clinical signs and pneumonia in intensively housed young 
dogs. 
Infected dogs should be quarantined and the environment thoroughly disinfected to prevent spread 
as the bacterium is relatively resistant when residing within mucus from nasal secretions. Water and 
food bowls, bedding and even leads can be a source of infection for other dogs. The bacterium is, as 
the name implies, zoonotic and has been isolated from a wide range of different species including 
humans where it has been linked albeit rarely with severe infections (Eyre et al., 2010; Pelkonen et al., 
2013) and in at least one case this has been linked directly back to contact with a dog suffering from 
pneumonia (Abbott et al., 2010). 
Data from SAVSNET between 2010 and 2017 records 144 canine samples from which S. zooepidemicus 
was cultured (Table 2). Seventy five (52.1%) samples were from the respiratory tract (nose, trachea or 
oropharynx). The next most frequent site for S. zooepidemicus culture were abscesses (n=22; 15.3%). 
There was no seasonal pattern for the cultured samples from S. zooepidemicus. Infection with the 
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bacterium is not always associated with clinical disease, and ‘carrier’ animals may occur, and thus 
there are likely to be as yet unknown host and environmental factors which are involved in the clinical 
expression of disease. Indeed, infections with S. zooepidemicus are more frequent in 
kennelled/shelter dogs, but then they are rarely actually swabbed and PCR analysis performed and 
consequently the infection in this population is likely underestimated (Priestnall et al., 2010). Although 
it is rarer in family pets, SAVSNET is keen to highlight the signs to owners, particularly if they regularly 
visit kennels or attend events where large groups of animals gather. Current research is focussed on 
a greater understanding of the bacterium genetically and whether specific sequence types are 
associated with more severe disease.  
 
Global perspective 
Eyeworm (Thelazzia callipaeda) in imported dogs 
Thelazzia callipaeda (T. calliaeda) is a vector borne nematode transmitted by fruit flies. Adults live in 
ocular and periocular tissues in a wide range of mammals including dogs, cats and humans. The disease 
is endemic and locally transmitted in wide areas of mainland Europe. Cases are now being seen in the 
UK in dogs that have recently come to the UK, including rescue animals (Graham-Brown et al., 2017). 
Clinical signs range from inapparent to severe corneal ulceration. To date only milbemycin and 
moxidectin have been licensed for the treatment of ocular thelaziosis. A search of consultation data 
from veterinary practices participating in SAVSNET found no reference to the disease, confirming 
infection is likely to be currently rare. However, the intermediate host in Europe, the fruit fly Phortica 
variegate, which transmits larvae while feeding on lacrimal secretions, are already resident in 
southern England, creating the potential for the disease to become established here. 
 
Canine Influenza virus in the United States of America and now Canada 
Canine influenza (CI) is caused by two strains of influenza, H3N8 that crossed the species barrier from 
horses to dogs in the United States of America (USA), and H3N2, that was probably transmitted from 
birds to dogs in Asia and subsequently imported into the USA, possibly by dogs being rescued. Both 
viruses continues to circulate in the USA. In January 2018, the first cases of CI H3N2 were confirmed in 
Canada. Neither virus is known to infect humans. Vaccines are licensed for control in the USA, and 
owners there are advised to avoid areas crowded with dogs when the virus is known to be actively 
circulating. To date there is no evidence for the virus in the UK, but clearly dog travel is one route that 
it may arrive.   
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Conclusion 
This is the fifth Small Animal Disease Surveillance (SADS) report, which highlights the importance of 
respiratory infections in UK pet animals, and in particular infection with Streptococcus zooepidemicus 
due to its severe nature and its zoonotic potential. As we collect data for longer, our estimates of 
changes in disease burden will become more refined, allowing more targeted local and perhaps national 
interventions. Anonymised data can be accessed for research by contacting the authors. SAVSNET 
welcomes your feedback. 
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Tables 
Table 1: Number and percentage of the main clinical signs in 988 cats and 2089 dogs presenting with 
respiratory disease* to SAVSNET veterinary premises in the UK, from January 2017 to December 2017.  
Clinical sign Number (%) of cats Number (%) of dogs 
Coughing 268 (27.1) 1498 (71.7) 
Sneezing 447 (45.2)  272 (13.0) 
Nasal discharge 279 (28.2) 157 (7.5) 
Dyspnoea 222 (22.5) 275 (13.2) 
Conjunctivitis and/or ocular discharge 138 (14.0) 48 (2.3) 
Lethargy 100 (10.1) 110 (5.3) 
Pyrexia 43 (4.4) 76 (3.6) 
* The same animal could present with more than one clinical sign per consultation 
Table 2: Number and percentage of 197 laboratory samples where Streptococcus equi subsp. 
zooepidemicus was isolated, from 2010 to 2017.  
Sampling site Number of cats (%) Number of dogs (%) 
Number of guinea 
pigs (%) 
Abscess/ swelling 2 (9.1)  22 (15.3)  6 (19.4) 
Ear 9 (40.9) 4 (2.8) 1 (3.2) 
Eye   2 (1.4) 4 (12.9) 
Oro/pharyngeal   6 (4.2)   
Lymph node   1 (0.7) 1 (3.2) 
Nasal 8 (36.4) 53 (36.8) 16 (51.6) 
Not specified   9 (6.3)   
Tracheal/ bronchoalveolar 3 (13.6) 16 (11.1) 2 (6.5) 
Urine   1 (0.7)   
Vaginal   19 (13.2)   
Wound   11 (7.6) 1 (3.2) 
Total 22 144 31 
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Figures 
 
FIG 1: Kernel intensity ratio surface of England and Wales showing the relative risk of cats and dogs 
being presented with respiratory disease by season from January 2017 to December 2017. The colours 
for relative risk have been categorised using the four cut-offs that divide the results obtained from 
cats during spring into five equal-size groups (quintiles) each containing 20 per cent of all results. The 
areas with not enough data for estimation of the relative risk are coloured in white.  
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FIG 2: Monthly percentage of dog sample submissions testing PCR positive for canine respiratory 
coronavirus, from January 2010 to December 2017. 
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FIG 3: Rate per weekly and monthly consultations for gastrointestinal, pruritus and respiratory 
disease in a UK veterinary-visiting population of cats and dogs, between January 2014 and December 
2017. The shaded areas around the solid lines depict a smoothing 95% Confidence Intervals of the 
weekly values by a locally weighted regression (Cleveland and Devlin, 1988). 
 
